ESC is proud to partner with the research organization Skin Investigation Network (SkIN) of Canada to help move Canadian research on atopic dermatitis forward. Recently, SkIN Canada has completed their priority setting project to better understand what priorities patients and health care providers have for AD research.
Top 10 atopic dermatitis AD research priorities:
- What can be done to prevent the development of atopic dermatitis in the first place?
- How can we predict which patients will respond to which treatments for atopic dermatitis and which patients will not respond?
- What is the difference in the prevalence, presentation, and management of atopic dermatitis between patients of different ethnicities and skin tones?
- What causes flares in atopic dermatitis?
- What are the molecular pathways involved in the development of atopic dermatitis that can be targeted by novel treatment?
- How do the environment, “good” bacteria, and genetics influence atopic dermatitis?
- Does restoring the skin’s protective barrier improve atopic dermatitis outcomes, and if so, how can it be repaired?
- What factors drive immune responses that contribute to atopic dermatitis, and how does managing these factors affect disease outcomes?
- How can clinically meaningful subtypes of atopic dermatitis be defined based on age at onset, genetics, environmental factors, and clinical features?
- What is the relationship between atopic dermatitis and immune-regulatory conditions (e.g., autoimmune diseases, asthma, allergies)?
Click here to learn more about the study.
To learn more about SkIN Canada, visit skincanada.org
October 2023
